Palmitoleic Acid Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease
Starting soon · Phase 4
Conditions studied: Crohn's Disease
In brief
This study aims to evaluate whether the combination of palmitoleic acid with infliximab can improve intestinal mucosal healing in patients with Crohn's disease compared with infliximab alone.
Key facts
- Study ID
- NCT07417696
- Run by
- Chinese Medical Association
- People needed
- 400
- Starts
- 2026-04-01
- Expected to finish
- 2029-03-31
- Last updated by the study team
- 2026-02-18
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients aged 18 to 75 years.
- Established diagnosis of Crohn's disease confirmed by radiologic, histologic, or endoscopic evidence.
- Active Crohn's disease at screening, defined as a Crohn's Disease Activity Index (CDAI) score between 220 and 450 (inclusive).
- Adequate cardiac, renal, and hepatic function, as assessed by the investigator based on screening laboratory tests, physical examination, and medical history, without findings that would pose an undue risk for study participation.
- Willingness and ability to provide written informed consent.
- Agreement to undergo all scheduled study procedures, including up to 3 endoscopic evaluations.
You may not qualify if…
- Use of any biologic therapy (e.g., infliximab, adalimumab, ustekinumab, vedolizumab) within 8 weeks prior to screening.
- Use of supplements containing fish oil or other lipid supplements (e.g., macadamia oil, krill oil, flaxseed, primrose oil, sea buckthorn oil) within 8 weeks prior to screening.
- History of any intestinal resection or other Crohn's disease-related surgery.
- History of or active chronic or recurrent infectious disease.
- History of or current malignancy.
- Pregnancy, lactation, or intention to become pregnant during the study period.
- Known hypersensitivity to infliximab or palmitoleic acid preparations.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.